WANBURYPharmaceuticals
Wanbury Ltd — Profit & Loss Statement
₹221.95
+0.00%
Wanbury Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 0.17 Cr | -0.19 Cr | 0.00 | — |
| Tax Rate For Calcs | 0.30 | 0.01 | 0.30 | 0.00 | — |
| Normalized EBITDA | 79.81 Cr | 72.99 Cr | 24.11 Cr | 41.23 Cr | — |
| Total Unusual Items | 0.00 | 25.56 Cr | -0.62 Cr | 71.96 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 25.56 Cr | -0.62 Cr | 71.96 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 30.53 Cr | 55.96 Cr | -10.40 Cr | 81.47 Cr | — |
| Reconciled Depreciation | 13.31 Cr | 13.03 Cr | 12.38 Cr | 11.45 Cr | — |
| Reconciled Cost Of Revenue | 294.48 Cr | 303.59 Cr | 309.02 Cr | 305.87 Cr | — |
| EBITDA | 79.81 Cr | 98.55 Cr | 23.49 Cr | 113.19 Cr | — |
| EBIT | 66.50 Cr | 85.52 Cr | 11.11 Cr | 101.74 Cr | — |
| Net Interest Income | -36.95 Cr | -29.18 Cr | -20.98 Cr | -19.94 Cr | — |
| Interest Expense | 36.95 Cr | 29.18 Cr | 21.39 Cr | 20.61 Cr | — |
| Normalized Income | 30.53 Cr | 30.57 Cr | -9.96 Cr | 9.51 Cr | — |
| Net Income From Continuing And Discontinued Operation | 30.53 Cr | 55.96 Cr | -10.40 Cr | 81.47 Cr | — |
| Total Expenses | 536.51 Cr | 518.68 Cr | 486.31 Cr | 478.09 Cr | — |
| Diluted Average Shares | 3.40 Cr | 3.31 Cr | 3.27 Cr | 3.23 Cr | — |
| Basic Average Shares | 3.28 Cr | 3.27 Cr | 3.27 Cr | 3.22 Cr | — |
| Diluted EPS | 8.98 | 16.89 | -3.18 | 25.21 | — |
| Basic EPS | 9.32 | 17.10 | -3.18 | 25.29 | — |
| Diluted NI Availto Com Stockholders | 30.53 Cr | 55.96 Cr | -10.40 Cr | 81.47 Cr | — |
| Net Income Common Stockholders | 30.53 Cr | 55.96 Cr | -10.40 Cr | 81.47 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 30.53 Cr | 55.96 Cr | -10.40 Cr | 81.47 Cr | — |
| Net Income Including Noncontrolling Interests | 30.53 Cr | 55.96 Cr | -10.40 Cr | 81.47 Cr | — |
| Net Income Continuous Operations | 30.53 Cr | 55.96 Cr | -10.40 Cr | 81.47 Cr | — |
| Tax Provision | -0.98 Cr | 0.38 Cr | 0.11 Cr | -0.35 Cr | — |
| Pretax Income | 29.55 Cr | 56.34 Cr | -10.29 Cr | 81.13 Cr | — |
| Other Non Operating Income Expenses | 3.49 Cr | 0.90 Cr | 0.12 Cr | 0.42 Cr | — |
| Special Income Charges | 0.00 | 25.56 Cr | -0.63 Cr | 71.96 Cr | — |
| Net Non Operating Interest Income Expense | -36.95 Cr | -29.18 Cr | -20.98 Cr | -19.94 Cr | — |
| Interest Expense Non Operating | 36.95 Cr | 29.18 Cr | 21.39 Cr | 20.61 Cr | — |
| Operating Income | 63.00 Cr | 59.06 Cr | 11.86 Cr | 29.14 Cr | — |
| Operating Expense | 242.04 Cr | 215.09 Cr | 177.29 Cr | 172.22 Cr | — |
| Other Operating Expenses | 124.49 Cr | 115.13 Cr | 50.13 Cr | 44.74 Cr | — |
| Depreciation And Amortization In Income Statement | 13.31 Cr | 13.03 Cr | 12.38 Cr | 11.45 Cr | — |
| Depreciation Income Statement | 13.31 Cr | 13.03 Cr | 12.33 Cr | 11.32 Cr | — |
| Gross Profit | 305.04 Cr | 274.15 Cr | 189.15 Cr | 201.36 Cr | — |
| Cost Of Revenue | 294.48 Cr | 303.59 Cr | 309.02 Cr | 305.87 Cr | — |
| Total Revenue | 599.51 Cr | 577.74 Cr | 498.18 Cr | 507.24 Cr | — |
| Operating Revenue | 599.51 Cr | 577.74 Cr | 498.18 Cr | 507.24 Cr | — |
| Interest Income | — | 0.38 Cr | 0.42 Cr | 0.67 Cr | 0.40 Cr |
| Rent Expense Supplemental | — | 0.81 Cr | 0.77 Cr | 1.52 Cr | 2.91 Cr |
| Other Special Charges | — | -25.83 Cr | 0.63 Cr | -75.84 Cr | 0.09 Cr |
| Write Off | — | 0.02 Cr | 0.00 | 3.87 Cr | 3.53 Cr |
| Interest Income Non Operating | — | 0.38 Cr | 0.42 Cr | 0.67 Cr | 0.40 Cr |
| Amortization | — | 0.04 Cr | 0.05 Cr | 0.13 Cr | 0.21 Cr |
| Selling General And Administration | — | 43.65 Cr | 34.48 Cr | 43.66 Cr | 30.90 Cr |
| Selling And Marketing Expense | — | 26.61 Cr | 21.24 Cr | 31.19 Cr | 16.69 Cr |
| General And Administrative Expense | — | 17.05 Cr | 13.24 Cr | 12.46 Cr | 14.21 Cr |
| Rent And Landing Fees | — | 0.81 Cr | 0.77 Cr | 1.52 Cr | 2.91 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Wanbury Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.